Kroncef-T 281.25mg Injection
Marketer
Krontec Healthcare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Kroncef-T 281.25mg Injection
Ceftazidime/Tazobactam 281.25mg injection is a dual-action antibiotic indicated for a range of bacterial infections. Its mechanism involves inhibiting bacterial growth, thereby controlling infection spread. Administration must be strictly under medical guidance; consistent adherence to the prescribed dosage schedule is crucial for effective treatment. Premature cessation may compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical consultation. Allergic reactions (rash, pruritus, edema, dyspnea) demand prompt medical attention. Prior to commencing treatment, inform your physician of all current medications and pre-existing health conditions. Pregnant or lactating individuals require physician consultation. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and sufficient hydration are recommended to facilitate recovery. Your physician may order laboratory tests to monitor treatment response.
Primary Ingredients of Kroncef-T 281.25mg Injection
No text provided to rephrase.
Uses of Kroncef-T 281.25mg Injection
Infections caused by bacteria
Major Benefits of Kroncef-T 281.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Kroncef-T 281.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Kroncef-T 281.25mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Kroncef-T 281.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Kroncef-T 281.25mg Injection, offer a targeted antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to survive. Tazobactum, a beta-lactamase inhibitor, complements this action by countering bacterial resistance mechanisms, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
No adverse reactions are associated with the concomitant use of alcohol and Kroncef-T 281.25mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Kroncef-T 281.25mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; the available data from human trials, however, remains scarce.
Breast feedingCAUTION
The administration of Kroncef-T 281.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Kroncef-T 281.25mg Injection can lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Kroncef-T 281.25mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Kroncef-T 281.25mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Dosage alteration for Kroncef-T 281.25mg Injection is unnecessary in individuals with mild or moderate liver dysfunction.
What if you forget to take Kroncef-T 281.25mg Injection :
Omit a scheduled Kroncef-T 281.25mg Injection? Seek medical advice immediately.
Facts to Know About Kroncef-T 281.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently